LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier

Neurobiology of Aging
Thorsten PflanznerClaus U Pietrzik

Abstract

According to the "amyloid hypothesis", the amyloid-β (Aβ) peptide is the toxic intermediate driving Alzheimer's disease (AD) pathogenesis. Recent evidence suggests that the low density lipoprotein receptor-related protein 1 (LRP1) transcytoses Aβ out of the brain across the blood-brain barrier (BBB). To provide genetic evidence for LRP1-mediated transcytosis of Aβ across the BBB we analyzed Aβ transcytosis across primary mouse brain capillary endothelial cells (pMBCECs) derived from wild-type and LRP1 knock-in mice. Here, we show that pMBCECs in vitro express functionally active LRP1. Moreover, we demonstrate that LRP1 mediates transcytosis of [(125)I]-Aβ(1-40) across pMBCECs in both directions, whereas no role for LRP1-mediated Aβ degradation was detected. Analysis of [(125)I]-Aβ(1-40) transport across pMBCECs generated from mice harboring a knock-in mutation in the NPxYxxL endocytosis/sorting domain of endogenous LRP1 revealed a reduced Aβ clearance from brain-to-blood and blood-to-brain compared with wild-type derived pMBCECs. Therefore, for the first time, we present genetic evidence that LRP1 modulates the pathogenic actions of soluble Aβ in the brain by clearing Aβ across the BBB.

References

Mar 17, 1999·The Journal of Clinical Investigation·D M HoltzmanS M Paul
Jul 11, 2000·Nature Medicine·B V ZlokovicB Frangione
Sep 19, 2001·The Journal of Clinical Investigation·J Herz, D K Strickland
Apr 30, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Claus U PietrzikEdward H Koo
May 27, 2004·Journal of Peptide Science : an Official Publication of the European Peptide Society·Yann VerdierBotond Penke
May 25, 2005·International Journal of Experimental Pathology·Claus Pietrzik, Christian Behl
Aug 24, 2005·Nature Medicine·Zhenhua WuBerislav V Zlokovic
Dec 16, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rashid DeaneBerislav V Zlokovic
May 3, 2006·Journal of Neuropathology and Experimental Neurology·Constantin BourasPanteleimon Giannakopoulos
Nov 2, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Robert D BellBerislav V Zlokovic
Aug 19, 2007·Nature Medicine·Abhay SagareBerislav V Zlokovic
Feb 22, 2008·Current Alzheimer Research·Sebastian Jaeger, Claus U Pietrzik
Jun 19, 2008·Neurobiology of Disease·Elaine WaldronClaus U Pietrzik
Oct 30, 2008·The Journal of Biological Chemistry·Bruce A Yankner, Tao Lu
Nov 27, 2008·The Journal of Clinical Investigation·Rashid DeaneBerislav V Zlokovic
Dec 23, 2008·Nature Cell Biology·Robert D BellBerislav V Zlokovic
Dec 30, 2008·Neurochemistry International·Shinsuke NakagawaMasami Niwa
Oct 15, 2009·The Journal of Biological Chemistry·Takahisa Kanekiyo, Guojun Bu
Oct 27, 2009·Cellular and Molecular Life Sciences : CMLS·Sara M ReekmansClaus U Pietrzik

❮ Previous
Next ❯

Citations

Sep 29, 2011·Experimental Brain Research·Timo Wagner, Claus U Pietrzik
Jul 23, 2013·Molecular Neurodegeneration·Wladislaw MaierClaus U Pietrzik
Apr 7, 2011·Biological & Pharmaceutical Bulletin·Hideki Hayashi
Nov 16, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Takahisa KanekiyoGuojun Bu
May 21, 2014·Nature Reviews. Neurology·Hao DengJoseph Jankovic
Sep 9, 2011·Neuromolecular Medicine·Zhiyou CaiAnna Ratka
Feb 5, 2014·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Paul O'CallaghanXiao Zhang
Dec 4, 2014·Molecular Neurobiology·Min XiaJiaxiang Xiong
Dec 1, 2015·The Journal of Clinical Investigation·Steffen E StorckClaus U Pietrzik
Feb 2, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Thorsten PflanznerClaus U Pietrzik
May 9, 2012·Journal of Microencapsulation·Ian G TuckerHimang Mujoo
Jun 7, 2014·Frontiers in Aging Neuroscience·Takahisa Kanekiyo, Guojun Bu
Dec 8, 2014·Archives of Medical Research·Patricia Campos-BedollaMária A Deli
Nov 20, 2016·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Jenna L LeclercSylvain Doré
Jan 7, 2017·Journal of Alzheimer's Disease : JAD·Loqman A MohamedAmal Kaddoumi
Sep 14, 2017·International Journal of Molecular Sciences·Yu Yamazaki, Takahisa Kanekiyo
Dec 12, 2012·IUBMB Life·Ibolya E András, Michal Toborek
Dec 2, 2011·Médecine sciences : M/S·Fabien GosseletLaurence Fenart
Apr 12, 2013·Expert Opinion on Therapeutic Targets·Henna MartiskainenMikko Hiltunen
Jul 16, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Loqman A Mohamed, Amal Kaddoumi
Nov 20, 2016·Journal of Molecular Neuroscience : MN·Niyaz Mohammadzadeh HonarvarGerald Muench
Mar 8, 2019·Science Translational Medicine·Sophie NybergAlain Dabdoub
May 16, 2020·Frontiers in Neuroscience·Xing YuAnwen Shao
Aug 28, 2016·Acta Neuropathologica Communications·Johannes SteffenJens Pahnke
Jun 8, 2017·Frontiers in Cardiovascular Medicine·Hua MaoXinchun Pi
Apr 21, 2019·Molecular Neurobiology·Bart Van GoolAnton J M Roebroek
Apr 2, 2019·Frontiers in Cell and Developmental Biology·Ewa E Bres, Andreas Faissner
Aug 10, 2019·Nature Communications·Zui ZhangChangyou Zhan
Oct 21, 2018·Fluids and Barriers of the CNS·Stephen B Hladky, Margery A Barrand
Feb 4, 2021·The Journal of Experimental Medicine·Angeliki Maria NikolakopoulouBerislav V Zlokovic

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.